Abstract:Purpose/Objective: The objective of this research is to demonstrate the feasibility of using an ultrasonic tissue-typing technique to differentiate and potentially grade cancerous tissue inside the prostate. These studies were undertaken with the ultimate goal of localizing cancerous regions inside the prostate to guide tumor dose escalation for both IMRT and brachytherapy. Materials/Methods: Ultrasonic tissue-typing imaging reveals the physical properties of biological tissues noninvasively. Ultrasonic tissue typing using 1-D spectrum analysis has demonstrated the ability of identifying cancer-containing regions in the prostate (Feleppa 1997). Comparing the results from this ultrasonic technique to the results of prostate biopsies showed a high degree of accuracy with the area under the receiver-operating characteristic (ROC) curve of 0.85, a result superior to other known imaging methods. We have expanded the 1-D spectrum technique to 2-D to obtain 3-D distributions of microstructures using a sequence of 2-D spectrum analyses. Our 2-D spectrum technique analyzes radio-frequency ultrasonic echo signals and extracts features of the ultrasonic signals that are associated with properties of tissue microstructures. The 2-D method is capable of accurate assessment of asymmetric tissue features, which is a key factor in grading cancerous tissue, and hence overcomes the primary limitation of the original 1-D analysis. A theoretical model is developed to relate these measured spectral parameters to physical properties of tissue microstructures such as size, shape, orientation and acoustic impedance (stiffness). These parameters are: peak value of radially integrated spectral power (RISP); peak shift of RISP; 3-dB width of RISP; slope of angularly integrated spectral power (AISP); and intercept of AISP. Four patients with localized prostate cancer were enrolled in a feasibility study. In vivo 3-D prostate ultrasound radio-frequency (RF) data were acquired in a sequence of parallel scans which were 1 mm apart using a B&K Medical System Hawk with 7.5 MHz probe. The RF data were analyzed using a 2-D Fourier transform algorithm. The resulting spectral parameters were computed to quantitatively assess the prostatic tissue. Prostate needle biopsies were used as the gold standard. Results: From the theoretical model, we have derived closed form solutions that explicitly relate spectral parameters to the physical properties of internal biological tissue. Among these parameters, slope of AISP is sensitive to the size of the tissue microstructures; peak shift of RISP is sensitive to the orientation; peak value of RISP is sensitive to the concentration; 3-dB width of RISP is sensitive to the shape. In the initial study with four prostate cancer patients, we found that the 2-D spectral analysis results were consistent with the theoretical predictions in differentiating between cancerous and non-cancerous tissues, and low-grade and high-grade tumors. For example, decrease in the 3-dB width of RISP for the patient with high Gleason score could be due to the lack of symmetry or the loss of homogeneity of the prostatic tissue, which is indicative of high-grade cancer. Conclusions: Ultrasonic tissue-typing imaging using 2-D spectrum analysis method can contribute to the evaluation of physical properties of prostate tissue microstructures that can become the basis for segmenting cancer-containing regions and grading cancers inside prostate. Initial studies demonstrated the feasibility of clinically employing this ultrasonic imaging method for prostate cancer. As the radiation treatment technique advances, this localized tumor information will become indispensable for intraprostatic tumor dose escalation. We are now incorporating this ultrasonic tissue typing technique in our clinical trials of dose escalation (with IMRT and brachytherapy) for patients with localized prostate cancer.

Toward in Vivo Dosimetry for Prostate Radiotherapy with a Transperineal Ultrasound Array: A Simulation Study

Application of real-time transperineal ultrasound in radiotherapy of prostate cancer-4D analysis of intra-fractional prostate motion

Towards quantitative in vivo dosimetry using x‐ray acoustic computed tomography

Evaluation Of The Dosimetric Impact Of Interfractional Anatomical Variations On Prostate Proton Therapy Using Daily In-Room Ct Images

Intrafractional Prostate Motion and Dose Variation During Radiation Therapy for Prostate Cancer Using 4D-TPUS

3D in vivo dose verification in prostate proton therapy with deep learning-based proton-acoustic imaging

Design and simulation of a 2-D array flexible ultrasound transducer system for tissue characterization – A pilot study

Ultrasonic tissue-typing imaging for guiding dose escalation of prostate cancer radiotherapy

Ultrasound-based guidance of intensity-modulated radiation therapy

Toward real-time, volumetric dosimetry for FLASH-capable clinical synchrocyclotrons using protoacoustic imaging

Dual-Modality X-Ray-Induced Radiation Acoustic and Ultrasound Imaging for Real-Time Monitoring of Radiotherapy

Design and Characterization of a Novel Scintillator Array for In Vivo Monitoring During UHDR PBS Proton Therapy

Targeting and monitoring radiation therapy of prostate cancer using ultrasonic spectrum-analysis and neural-network classification for tissue-type imaging

Simulation study of protoacoustics as a real‐time in‐line dosimetry tool for FLASH proton therapy

Enhancing Image-Guided Radiation Therapy for Pancreatic Cancer: Utilizing Aligned Peak Response Beamforming in Flexible Array Transducers

SU-EE-A3-03: Incorporate the Imager's Performance Characteristics Into the Design of Prostate IMRT Dose Painting Protocols

Clinical implementation of MRI simulation for IMRT of prostate cancer

Quantitative analysis of 3-D conformal MRI-guided transurethral ultrasound therapy of the prostate: theoretical simulations

TU‐EE‐A3‐02: Registration of Ultrasound Tissue‐Typing Images with CT Images for Image‐Guided Prostate Cancer Radiation Therapy

Treatment Planning Strategies for Interstitial Ultrasound Ablation of Prostate Cancer

Biologic Target Volume Delineation and the Application of Three-Dimensional Ultrasound Image System in Hypofractional Radiotherapy for Prostate Cancer.